Clincosm LogoSign in Get a demo

Neoplasms

Showing NaN - NaN of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Sep 15, 2023

Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Jul 5, 2023

Tumors Trial in Worldwide (Encorafenib, Cetuximab, Oxaliplatin)

Recruiting
  • Neoplasms
  • Phoenix, Arizona
  • +396 more
Jan 25, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Tumors Trial in Belgium, Japan, United States (BI 907828, BI 754091, BI 754111)

Recruiting
  • Neoplasms
  • BI 907828
  • +2 more
  • Santa Monica, California
  • +16 more
Jan 23, 2023

Tumors Trial in Worldwide (CC-95251, Rituximab, Cetuximab)

Recruiting
  • Neoplasms
  • Birmingham, Alabama
  • +62 more
Jan 19, 2023

Tumors Trial in Worldwide (MK-4830, Pembrolizumab, Carboplatin)

Recruiting
  • Neoplasms
  • San Francisco, California
  • +31 more
Dec 23, 2022

Tumors Trial in Spain, United States (TSR-022, Nivolumab, TSR-042)

Recruiting
  • Neoplasms
  • Goodyear, Arizona
  • +71 more
Dec 9, 2022

Tumors Trial in United States (letetresgene autoleucel (GSK3377794), Cyclophosphamide, Fludarabine)

Completed
Has Results
  • Neoplasms
  • letetresgene autoleucel (GSK3377794)
  • +2 more
  • Tampa, Florida
  • +5 more
Oct 31, 2022

Tumors Trial in Worldwide (Dostarlimab)

Recruiting
  • Neoplasms
  • Dostarlimab
  • Birmingham, Alabama
  • +105 more
Nov 17, 2022

Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • +16 more
  • Duarte, California
  • +9 more
Nov 15, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Tumors Trial in Worldwide (CC-90011, Nivolumab)

Active, not recruiting
  • Neoplasms
  • Augusta, Georgia
  • +77 more
Nov 8, 2022

Tumors, Cancer Trial in New York (Expressive Helping)

Completed
  • Neoplasms
  • Cancer
  • Expressive Helping
  • New York, New York
    New York University
Oct 31, 2022

Tumors Trial in Worldwide (Letetresgene autoleucel (lete-cel, GSK3377794), Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Neoplasms
  • Letetresgene autoleucel (lete-cel, GSK3377794)
  • +2 more
  • Duarte, California
  • +36 more
Oct 28, 2022

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Tumors Trial in Australia, Canada, United States (feladilimab, Tremelimumab, Docetaxel)

Completed
Has Results
  • Neoplasms
  • Boston, Massachusetts
  • +7 more
Jul 28, 2022

Tumors Trial in Worldwide (Biopsy)

Completed
  • Neoplasms
  • Biopsy
  • San Francisco, California
  • +10 more
Aug 10, 2022

Tumors Trial in Worldwide (BI 907828)

Recruiting
  • Neoplasms
  • BI 907828
  • New Haven, Connecticut
  • +13 more
Aug 8, 2022

Tumors Trial in Worldwide (Gene-modified (GM) T cell therapy)

Recruiting
  • Neoplasms
  • Gene-modified (GM) T cell therapy
  • Birmingham, Alabama
  • +173 more
Aug 1, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Tumors Trial in Worldwide (GSK3326595, Pembrolizumab)

Active, not recruiting
  • Neoplasms
  • Denver, Colorado
  • +16 more
Jun 23, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Tumors Trial in Chile, United States (VIP152 (BAY 1251152), VIP152 (BAY 1251152) 30 mg, Keytruda)

Recruiting
  • Neoplasms
  • VIP152 (BAY 1251152)
  • +3 more
  • Springdale, Arkansas
  • +12 more
Mar 24, 2022